United States Chronic Gonadotropin Market Report 2017

October 2017 | 104 pages | ID: U938F380030PEN
QYResearch

Abstracts

In this report, the United States Chronic Gonadotropin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Chronic Gonadotropin in these regions, from 2012 to 2022 (forecast).

United States Chronic Gonadotropin market competition by top manufacturers/players, with Chronic Gonadotropin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bristol Mayer Squibb Company
• Emd Serono, Inc.
• Merck & Co., Inc.
• Actiza Pharmaceutical Private Limited
• Tissue Pharma
• Ocean pharmaceuticals
• Ferring B.V.
• Fresenius Kabi Usa, Llc
• Zota Pharmaceuticals Pvt. Ltd
• United Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Technology
• Recombinant Technology
• Natural Source Extraction
• By Type
• Human Chronic Gonadotropin
• Animal Chronic Gonadotropin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Chronic Gonadotropin for each application, including

• Hospital
• Medical Centres
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Chronic Gonadotropin Market Report 2017

1 CHRONIC GONADOTROPIN OVERVIEW

1.1 Product Overview and Scope of Chronic Gonadotropin
1.2 Classification of Chronic Gonadotropin by Product Category
  1.2.1 United States Chronic Gonadotropin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Chronic Gonadotropin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Recombinant Technology
  1.2.4 Natural Source Extraction
1.3 United States Chronic Gonadotropin Market by Application/End Users
  1.3.1 United States Chronic Gonadotropin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Centres
  1.3.4 Others
1.4 United States Chronic Gonadotropin Market by Region
  1.4.1 United States Chronic Gonadotropin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Chronic Gonadotropin Status and Prospect (2012-2022)
  1.4.3 Southwest Chronic Gonadotropin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Chronic Gonadotropin Status and Prospect (2012-2022)
  1.4.5 New England Chronic Gonadotropin Status and Prospect (2012-2022)
  1.4.6 The South Chronic Gonadotropin Status and Prospect (2012-2022)
  1.4.7 The Midwest Chronic Gonadotropin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Chronic Gonadotropin (2012-2022)
  1.5.1 United States Chronic Gonadotropin Sales and Growth Rate (2012-2022)
  1.5.2 United States Chronic Gonadotropin Revenue and Growth Rate (2012-2022)

2 UNITED STATES CHRONIC GONADOTROPIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Chronic Gonadotropin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Chronic Gonadotropin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Chronic Gonadotropin Average Price by Players/Suppliers (2012-2017)
2.4 United States Chronic Gonadotropin Market Competitive Situation and Trends
  2.4.1 United States Chronic Gonadotropin Market Concentration Rate
  2.4.2 United States Chronic Gonadotropin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Chronic Gonadotropin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CHRONIC GONADOTROPIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Chronic Gonadotropin Sales and Market Share by Region (2012-2017)
3.2 United States Chronic Gonadotropin Revenue and Market Share by Region (2012-2017)
3.3 United States Chronic Gonadotropin Price by Region (2012-2017)

4 UNITED STATES CHRONIC GONADOTROPIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Chronic Gonadotropin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Chronic Gonadotropin Revenue and Market Share by Type (2012-2017)
4.3 United States Chronic Gonadotropin Price by Type (2012-2017)
4.4 United States Chronic Gonadotropin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CHRONIC GONADOTROPIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Chronic Gonadotropin Sales and Market Share by Application (2012-2017)
5.2 United States Chronic Gonadotropin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CHRONIC GONADOTROPIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bristol Mayer Squibb Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Chronic Gonadotropin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol Mayer Squibb Company Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Emd Serono, Inc.
  6.2.2 Chronic Gonadotropin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Emd Serono, Inc. Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck & Co., Inc.
  6.3.2 Chronic Gonadotropin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck & Co., Inc. Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Actiza Pharmaceutical Private Limited
  6.4.2 Chronic Gonadotropin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Actiza Pharmaceutical Private Limited Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Tissue Pharma
  6.5.2 Chronic Gonadotropin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tissue Pharma Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ocean pharmaceuticals
  6.6.2 Chronic Gonadotropin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ocean pharmaceuticals Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ferring B.V.
  6.7.2 Chronic Gonadotropin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ferring B.V. Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Fresenius Kabi Usa, Llc
  6.8.2 Chronic Gonadotropin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Fresenius Kabi Usa, Llc Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Zota Pharmaceuticals Pvt. Ltd
  6.9.2 Chronic Gonadotropin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Zota Pharmaceuticals Pvt. Ltd Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 United Biotech
  6.10.2 Chronic Gonadotropin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 United Biotech Chronic Gonadotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 CHRONIC GONADOTROPIN MANUFACTURING COST ANALYSIS

7.1 Chronic Gonadotropin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chronic Gonadotropin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Chronic Gonadotropin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chronic Gonadotropin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CHRONIC GONADOTROPIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Chronic Gonadotropin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Chronic Gonadotropin Sales Volume Forecast by Type (2017-2022)
11.3 United States Chronic Gonadotropin Sales Volume Forecast by Application (2017-2022)
11.4 United States Chronic Gonadotropin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Chronic Gonadotropin
Figure United States Chronic Gonadotropin Market Size (MT) by Type (2012-2022)
Figure United States Chronic Gonadotropin Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant Technology Product Picture
Figure Natural Source Extraction Product Picture
Figure United States Chronic Gonadotropin Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Chronic Gonadotropin by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Centres Examples
Table Key Downstream Customer in Medical Centres
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Chronic Gonadotropin Market Size (Million USD) by Region (2012-2022)
Figure The West Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Chronic Gonadotropin Sales (MT) and Growth Rate (2012-2022)
Figure United States Chronic Gonadotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Chronic Gonadotropin Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Chronic Gonadotropin Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Chronic Gonadotropin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Chronic Gonadotropin Sales Share by Players/Suppliers
Figure 2017 United States Chronic Gonadotropin Sales Share by Players/Suppliers
Figure United States Chronic Gonadotropin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Chronic Gonadotropin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Chronic Gonadotropin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Chronic Gonadotropin Revenue Share by Players/Suppliers
Figure 2017 United States Chronic Gonadotropin Revenue Share by Players/Suppliers
Table United States Market Chronic Gonadotropin Average Price (K USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Chronic Gonadotropin Average Price (K USD/Kg) of Key Players/Suppliers in 2016
Figure United States Chronic Gonadotropin Market Share of Top 3 Players/Suppliers
Figure United States Chronic Gonadotropin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Chronic Gonadotropin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Chronic Gonadotropin Product Category
Table United States Chronic Gonadotropin Sales (MT) by Region (2012-2017)
Table United States Chronic Gonadotropin Sales Share by Region (2012-2017)
Figure United States Chronic Gonadotropin Sales Share by Region (2012-2017)
Figure United States Chronic Gonadotropin Sales Market Share by Region in 2016
Table United States Chronic Gonadotropin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Chronic Gonadotropin Revenue Share by Region (2012-2017)
Figure United States Chronic Gonadotropin Revenue Market Share by Region (2012-2017)
Figure United States Chronic Gonadotropin Revenue Market Share by Region in 2016
Table United States Chronic Gonadotropin Price (K USD/Kg) by Region (2012-2017)
Table United States Chronic Gonadotropin Sales (MT) by Type (2012-2017)
Table United States Chronic Gonadotropin Sales Share by Type (2012-2017)
Figure United States Chronic Gonadotropin Sales Share by Type (2012-2017)
Figure United States Chronic Gonadotropin Sales Market Share by Type in 2016
Table United States Chronic Gonadotropin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Chronic Gonadotropin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chronic Gonadotropin by Type (2012-2017)
Figure Revenue Market Share of Chronic Gonadotropin by Type in 2016
Table United States Chronic Gonadotropin Price (K USD/Kg) by Types (2012-2017)
Figure United States Chronic Gonadotropin Sales Growth Rate by Type (2012-2017)
Table United States Chronic Gonadotropin Sales (MT) by Application (2012-2017)
Table United States Chronic Gonadotropin Sales Market Share by Application (2012-2017)
Figure United States Chronic Gonadotropin Sales Market Share by Application (2012-2017)
Figure United States Chronic Gonadotropin Sales Market Share by Application in 2016
Table United States Chronic Gonadotropin Sales Growth Rate by Application (2012-2017)
Figure United States Chronic Gonadotropin Sales Growth Rate by Application (2012-2017)
Table Bristol Mayer Squibb Company Basic Information List
Table Bristol Mayer Squibb Company Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Bristol Mayer Squibb Company Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Bristol Mayer Squibb Company Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Bristol Mayer Squibb Company Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Emd Serono, Inc. Basic Information List
Table Emd Serono, Inc. Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Emd Serono, Inc. Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Emd Serono, Inc. Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Emd Serono, Inc. Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Actiza Pharmaceutical Private Limited Basic Information List
Table Actiza Pharmaceutical Private Limited Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Actiza Pharmaceutical Private Limited Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Actiza Pharmaceutical Private Limited Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Actiza Pharmaceutical Private Limited Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Tissue Pharma Basic Information List
Table Tissue Pharma Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Tissue Pharma Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Tissue Pharma Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Tissue Pharma Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Ocean pharmaceuticals Basic Information List
Table Ocean pharmaceuticals Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Ocean pharmaceuticals Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Ocean pharmaceuticals Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Ocean pharmaceuticals Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Ferring B.V. Basic Information List
Table Ferring B.V. Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Ferring B.V. Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Ferring B.V. Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Ferring B.V. Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Fresenius Kabi Usa, Llc Basic Information List
Table Fresenius Kabi Usa, Llc Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Fresenius Kabi Usa, Llc Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Fresenius Kabi Usa, Llc Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Fresenius Kabi Usa, Llc Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Zota Pharmaceuticals Pvt. Ltd Basic Information List
Table Zota Pharmaceuticals Pvt. Ltd Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Zota Pharmaceuticals Pvt. Ltd Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure Zota Pharmaceuticals Pvt. Ltd Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure Zota Pharmaceuticals Pvt. Ltd Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table United Biotech Basic Information List
Table United Biotech Chronic Gonadotropin Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure United Biotech Chronic Gonadotropin Sales Growth Rate (2012-2017)
Figure United Biotech Chronic Gonadotropin Sales Market Share in United States (2012-2017)
Figure United Biotech Chronic Gonadotropin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chronic Gonadotropin
Figure Manufacturing Process Analysis of Chronic Gonadotropin
Figure Chronic Gonadotropin Industrial Chain Analysis
Table Raw Materials Sources of Chronic Gonadotropin Major Players/Suppliers in 2016
Table Major Buyers of Chronic Gonadotropin
Table Distributors/Traders List
Figure United States Chronic Gonadotropin Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Chronic Gonadotropin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Chronic Gonadotropin Price (K USD/Kg) Trend Forecast (2017-2022)
Table United States Chronic Gonadotropin Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Chronic Gonadotropin Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Chronic Gonadotropin Sales Volume (MT) Forecast by Type in 2022
Table United States Chronic Gonadotropin Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Chronic Gonadotropin Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Chronic Gonadotropin Sales Volume (MT) Forecast by Application in 2022
Table United States Chronic Gonadotropin Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Chronic Gonadotropin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Chronic Gonadotropin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Chronic Gonadotropin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources